权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis

早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用

基本信息

批准号：
10689682
负责人：
Erik W Settles
金额：
$ 31.55万
依托单位：
NORTHERN ARIZONA UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-08-24 至 2027-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10689682
关键词：
2019-nCoV Acceleration Animal Model Animals Antibiotics Antibody Response Antigens Arizona Attenuated Bacterial Pneumonia Biological Assay Breeding CD4 Positive T Lymphocytes CD8-Positive T-Lymphocytes COVID-19 California Cell Count Cell Separation Cells Clinical Clone Cells Coccidioides Coccidioides immitis Coccidioides posadasii Coccidioidomycosis Communities Complex County Cryopreservation DNA Diagnosis Diagnostic Diagnostic Procedure Diagnostic tests Disease Disease Outcome Epitopes Future Goals HIV Infections Human Immune Immune response Immunity Immunize Individual Infection Life Link Macaca Macaca nemestrina Medical Methods Modeling Mus Nucleic Acid Vaccines Patients Peptide Synthesis Peptides Performance Peripheral Blood Mononuclear Cell Phenotype Play Population Prevalence Primates Privatization Productivity Proteins RNA Reporting Research Project Grants Resources Risk Role Sampling Serology Serum Sorting Specimen Symptoms T cell receptor repertoire sequencing T cell response T-Cell Activation T-Cell Receptor T-Lymphocyte T-Lymphocyte Epitopes Techniques Test Result Testing Universities Vaccinated Vaccination Vaccines Viral Pneumonia Virulence Virulent Washington Whole Blood Work accurate diagnosis clinical research site cross reactivity desert fever disease diagnosis experience fungus human disease immunogenic immunogenicity in vivo model development novel novel diagnostics pathogen pulmonary symptom rapid diagnosis receptor response vaccine candidate vaccine development vaccine strategy vaccine-induced immunity

项目摘要

PROJECT SUMMARY/ABSTRACT Coccidioidomycosis or Valley Fever (VF), is caused by the fungus Coccidioides immitis and C. posadasii with highest reported prevalence in Arizona and California. Due to similar clinical presentations, VF is frequently misdiagnosed and mistreated as bacterial or viral pneumonia, resulting in unnecessary antibiotics and longer times to resolve illness. Patients lose productivity and experience symptoms for many months. Severe CM manifests in <5% of symptomatic cases but can be life-threatening. T cell responses plays an important role in vaccine induced protection in animal models. In fact, this activity appears to be critical for defense against Coccidioides in humans, as evidenced by the fact that humans with low CD4+ T cell counts due to HIV infection are at increased risk of severe VF. The objective of this proposal is to identify T cell clones and their associated epitopes that are generated in human patients and animal models. For Coccidioides spp. epitopes, we will focus on previously confirmed and novel in vivo early expressed antigens and we will link these epitopes to their TCRs using a T cell peptide stimulation strategy. Our hypothesis is that epitopes from these Coccidioides antigens drive patient TCR profiles and, hence, will contain “public” TCR sequences that can be used for VF diagnosis and prioritize vaccine candidates. We predict that the TCR profiles are indicative of immune and disease states. We will address this hypothesis by deep TCR sequencing of activated T cells stimulated with Coccidioides peptide epitopes. We will identify TCRs specific to these and other Coccidioides proteins in patient samples from both Arizona (C. posadasii) and California (C. immitis). We will also confirm that mouse and macaque T cells detect epitopes from these antigens to aid in Coccidioides challenge model development. In addition, the immunogenic Coccidioides antigens will be evaluated for protection in these animal models after vaccination. Finally, we will generate a TCR sequencing diagnostic test to detect VF patients. Specifically, we aim to: 1) Characterize C. posadasii and C. immitis epitopes and associated T cell clones (TCR) in human specimens using T cell receptor sequencing and standard cell sorting techniques, 2) Determine TCRs and epitopes recognized during animal model (mouse and pig-tailed macaque) challenge, natural exposure, and RNA/DNA vaccinations, and 3) Compare the sensitivity between traditional serology and TCR sequencing using endemic and non-endemic populations. If successful, this project will make available to the community a novel set of T cell epitopes for VF in humans, mice, and macaques. The TCR sequences can be used to develop next generation diagnostics and aid in antigens identification for vaccination. Finally, T cell clonotypes specific to these epitopes will be correlated to protection through the models and disease outcomes in VF patients.

项目总结/文摘